Literature DB >> 24759824

Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient.

Jori Symons1, Linos Vandekerckhove2, Gero Hütter3, Annemarie M J Wensing1, Petra M van Ham1, Steven G Deeks4, Monique Nijhuis1.   

Abstract

The "Berlin patient" is the first patient cured of HIV-1 infection after allogeneic transplantation with nonfunctional CCR5 coreceptor stem cells. We demonstrate that CXCR4-predicted minority viruses present prior to transplantation were unable to rebound after transplantation due to their dependence on CCR5 for replication and high genetic barrier toward CXCR4 usage.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Berlin-Patient; HIV; coreceptor; cure; stem cell transplantation

Mesh:

Substances:

Year:  2014        PMID: 24759824      PMCID: PMC4990826          DOI: 10.1093/cid/ciu284

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses.

Authors:  M A Vodicka; W C Goh; L I Wu; M E Rogel; S R Bartz; V L Schweickart; C J Raport; M Emerman
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

2.  Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.

Authors:  Y Isaka; A Sato; S Miki; S Kawauchi; H Sakaida; T Hori; T Uchiyama; A Adachi; M Hayami; T Fujiwara; O Yoshie
Journal:  Virology       Date:  1999-11-10       Impact factor: 3.616

Review 3.  European guidelines on the clinical management of HIV-1 tropism testing.

Authors:  L P R Vandekerckhove; A M J Wensing; R Kaiser; F Brun-Vézinet; B Clotet; A De Luca; S Dressler; F Garcia; A M Geretti; T Klimkait; K Korn; B Masquelier; C F Perno; J M Schapiro; V Soriano; A Sönnerborg; A-M Vandamme; C Verhofstede; H Walter; M Zazzi; C A B Boucher
Journal:  Lancet Infect Dis       Date:  2011-03-21       Impact factor: 25.071

4.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

Authors:  R A Fouchier; M Groenink; N A Kootstra; M Tersmette; H G Huisman; F Miedema; H Schuitemaker
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

Authors:  Kristina Allers; Gero Hütter; Jörg Hofmann; Christoph Loddenkemper; Kathrin Rieger; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2010-12-08       Impact factor: 22.113

6.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

7.  Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.

Authors:  Jori Symons; Steven F L van Lelyveld; Andy I M Hoepelman; Petra M van Ham; Dorien de Jong; Annemarie M J Wensing; Monique Nijhuis
Journal:  J Antimicrob Chemother       Date:  2011-01-28       Impact factor: 5.790

8.  Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.

Authors:  Carolina Garrido; Vanessa Roulet; Natalia Chueca; Eva Poveda; Antonio Aguilera; Katharina Skrabal; Natalia Zahonero; Silvia Carlos; Federico García; Jean Louis Faudon; Vincent Soriano; Carmen de Mendoza
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

9.  Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.

Authors:  Mark A Jensen; Fu-Sheng Li; Angélique B van 't Wout; David C Nickle; Daniel Shriner; Hong-Xia He; Sherry McLaughlin; Raj Shankarappa; Joseph B Margolick; James I Mullins
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more
  16 in total

1.  Second example reported of a stem-cell transplant in the clinic leading to HIV remission.

Authors:  Timothy J Henrich
Journal:  Nature       Date:  2019-04       Impact factor: 49.962

Review 2.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

3.  Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.

Authors:  Kersten K Koelsch; Thomas A Rasmussen; William J Hey-Nguyen; Chester Pearson; Yin Xu; Michelle Bailey; Katherine H Marks; Sarah C Sasson; Mark S Taylor; Robyn Tantau; Solange Obeid; Brad Milner; Orla Morrissey; Angie N Pinto; Kazuo Suzuki; Michael P Busch; Sheila M Keating; Philipp Kaiser; Steven Yukl; Joseph K Wong; Bonnie M Hiener; Sarah Palmer; John Zaunders; Jeffrey J Post; Derek J Chan; Sharon Avery; Sam T Milliken; Anthony D Kelleher; Sharon R Lewin; David A Cooper
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

Review 4.  Cell and gene therapy strategies to eradicate HIV reservoirs.

Authors:  Chelsea Spragg; Harshana De Silva Feelixge; Keith R Jerome
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

5.  Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.

Authors:  Russell E Baumann; Amy A Rogers; Hasnah B Hamdan; Harold Burger; Barbara Weiser; Wei Gao; Kathryn Anastos; Mary Young; William A Meyer; Rick L Pesano; Ron M Kagan
Journal:  AIDS Res Ther       Date:  2015-04-18       Impact factor: 2.250

6.  HIV cure research: a formidable challenge.

Authors:  Jintanat Ananworanich; Anthony S Fauci
Journal:  J Virus Erad       Date:  2015-01-01

7.  Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.

Authors:  Wannisa Khamaikawin; Saki Shimizu; Masakazu Kamata; Ruth Cortado; Yujin Jung; Jennifer Lam; Jing Wen; Patrick Kim; Yiming Xie; Sanggu Kim; Hubert Arokium; Angela P Presson; Irvin S Y Chen; Dong Sung An
Journal:  Mol Ther Methods Clin Dev       Date:  2017-12-01       Impact factor: 6.698

8.  Mechanistic Models Predict Efficacy of CCR5-Deficient Stem Cell Transplants in HIV Patient Populations.

Authors:  I Hosseini; F Mac Gabhann
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-02-16

Review 9.  Stem cell transplantation in strategies for curing HIV/AIDS.

Authors:  Gero Hütter
Journal:  AIDS Res Ther       Date:  2016-09-13       Impact factor: 2.250

Review 10.  Perspectives for immunotherapy: which applications might achieve an HIV functional cure?

Authors:  Vincent Vieillard; Shahin Gharakhanian; Olivier Lucar; Christine Katlama; Odile Launay; Brigitte Autran; Raphael Ho Tsong Fang; Joël Crouzet; Robert L Murphy; Patrice Debré
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.